GRF-CRIS Clinical Scientist Emerging Leader Programme
This is an exciting opportunity for a talented early career clinician scientist to develop their academic skills and expertise, placing them on a firm footing for a career as an independent clinical academic.
The aim of the GRF-CRIS Clinical Scientist Emerging Leader Programme is to provide competitive financial conditions and incentives for the early career of talented emerging young clinician scientists to lead projects, developing their research skills, academic skills, expertise and leadership on all types of cancer pathologies at the Gustave Roussy Institute.
This unique opportunity provides a pathway towards independence whilst facilitating collaborative research which ultimately translates to patient benefit.
Call for Applications 2025 – GRF-CRIS Clinical Scientist Emerging Leader Programme
In 2025, Gustave Roussy Foundation and CRIS Cancer ran the first GRF-CRIS Clinical Scientist Emerging Leader Programme call, to award 1 research grant, covering a three-year period, for the purposes of incentivizing clinical scientists to develop their career at the Gustave Roussy Institute.
The maximum grant awarded will be €210,000, which will be spread over three annual instalments of up to €70,000 a year.
The call for applications took place betwen 1 January 2025 and 28 February 2025 at 23:59 (Central European Time – CET).
All applications were to be submitted by email to RLtrials@gustaveroussy.fr and convocatorias@criscancer.org during the application submission period for the 2025 call.
Applications for the 2025 call are now CLOSED.
To download the Terms & Conditions of the call, click here
To download the needed Templates, click here
——————————————————————————————————
GR-CRIS Real-Life Trials in Oncology Programme
CRIS Cancer and Gustave Roussy are partnering to support the development of practice-changing or practice-informing clinical trials in France and Spain.
The aim of the GR-CRIS Real-Life Trials in Oncology Programme is to provide competitive funding conditions to clinical researchers to develop «Real-life Trials / Pragmatic Trials» in France and Spain, understanding “Real-life Trials / Pragmatic Trial” as a type of clinical study designed to evaluate new treatment approaches under real world conditions that can be implemented in routine clinical practice across diverse healthcare settings.
Call for Applications 2025 – GR-CRIS Real-Life Trials in Oncology Programme
In 2025, Gustave Roussy and CRIS Cancer run the fourth GR-CRIS Real-Life Trials in Oncology Programme call.
The maximum grant awarded will be €1,500,000, which will be spread over the awarded proposals, for three years, with annual instalments of up to €500,000 a year.
The 2025 call for applications opens on 1 April 2025 and closes on 16 June 2025 at 23:59 (Central European Time – CET).
All applications must be submitted by filling the form https://forms.gle/GQd7HegBah6SXeHw5 during the application submission period for the 2025 call.
To download the Terms & Conditions of the 2025 call click here.
To download the needed Templates of the 2025 call click here.
